Active — Not RecruitingPhase 2

The Caffeine, Postoperative Delirium, and Change in Outcomes After Surgery (CAPACHINOS-2) Study

United States250 participantsStarted 2023-02-20

Plain-language summary

The objective of this study is to test the effects of caffeine on neurocognitive and clinical recovery after major surgery. Specifically, this trial tests the primary hypothesis that caffeine will reduce the incidence of postoperative delirium.

Who can participate

Age range70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Adult (\>/= 70 years old) undergoing non-cardiac, non-intracranial neurologic, non-major vascular surgery requiring general anesthesia with a planned admission for at least 48 hours.
✓. Stated willingness to comply with all study procedures and availability for the duration of the study.
✓. Provision of signed and dated informed consent form.

Exclusion criteria

✕. Emergency surgery
✕. Outpatient surgery
✕. Severe cognitive impairment precluding the capacity for informed consent
✕. Seizure disorder history
✕. Intolerance or allergy to caffeine (based on subjective reporting or objective documentation)
✕. Weight \>130 kg (as a 3 mg/kg dose would approach the upper limit of daily intake recommended by the FDA)
✕. Enrollment in conflicting research study
✕. Patients in acute liver failure

What they're measuring

Delirium

Timeframe: Day of surgery through afternoon of postoperative day three

Trial details

NCT IDNCT05574400

SponsorUniversity of Michigan

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-04-16

View on ClinicalTrials.gov More Postoperative Delirium trials